Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (544)
|
Core Tip (600)
|
Full Article (HTML) (2176)
|
Figures (1-1) (408)
|
Full Article (PDF)-1204K (167)
|
Full Article with Cover (PDF)-11949K (164)
|
Full Article (XML)-236K (101)
|
Audio-1342K (6)
|
Peer-Review Report-230K (108)
|
Answering Reviewers-97K (91)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (6333)
|
Similar Articles (77)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (597)
|
Core Tip (637)
|
Full Article (HTML) (1531)
|
Tables (1-1) (500)
|
Full Article (PDF)-358K (140)
|
Full Article with Cover (PDF)-11106K (159)
|
Full Article (XML)-54K (92)
|
Audio-1072K (10)
|
Peer-Review Report-236K (86)
|
Answering Reviewers-62K (79)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5261)
|
Similar Articles (19)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (649)
|
Core Tip (539)
|
Full Article (HTML) (5559)
|
Figures (1-2) (441)
|
Tables (1-5) (439)
|
Full Article (PDF)-1655K (252)
|
Full Article with Cover (PDF)-12399K (193)
|
Full Article (XML)-226K (109)
|
Audio-1259K (9)
|
Peer-Review Report-216K (95)
|
Answering Reviewers-145K (92)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (14)
|
Total Visits (9499)
|
Similar Articles (63)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (656)
|
Core Tip (578)
|
Full Article (HTML) (3430)
|
Figures (1-1) (435)
|
Full Article (PDF)-601K (248)
|
Full Article with Cover (PDF)-11346K (123)
|
Full Article (XML)-89K (102)
|
Audio-384K (5)
|
Peer-Review Report-180K (82)
|
Answering Reviewers-74K (93)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (16)
|
Total Visits (6997)
|
Similar Articles (336)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (631)
|
Core Tip (568)
|
Article Highlights (588)
|
Full Article (HTML) (2215)
|
Figures (1-4) (393)
|
Tables (1-3) (383)
|
Full Article (PDF)-1672K (148)
|
Full Article with Cover (PDF)-12418K (139)
|
Full Article (XML)-173K (90)
|
Audio-467K (6)
|
Peer-Review Report-182K (80)
|
Answering Reviewers-71K (113)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7063)
|
Similar Articles (2022)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes

World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (601)
|
Core Tip (603)
|
Article Highlights (698)
|
Full Article (HTML) (1988)
|
Figures (1-3) (467)
|
Tables (1-2) (424)
|
Full Article (PDF)-1874K (158)
|
Full Article with Cover (PDF)-12619K (144)
|
Full Article (XML)-114K (103)
|
Audio-386K (15)
|
Peer-Review Report-233K (103)
|
Answering Reviewers-161K (92)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8101)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication

World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (531)
|
Core Tip (510)
|
Article Highlights (583)
|
Full Article (HTML) (1425)
|
Figures (1-4) (377)
|
Full Article (PDF)-5746K (136)
|
Full Article with Cover (PDF)-16492K (117)
|
Full Article (XML)-96K (94)
|
Audio-3997K (6)
|
Peer-Review Report-192K (82)
|
Answering Reviewers-146K (90)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5622)
|
Similar Articles (42)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (586)
|
Core Tip (561)
|
Article Highlights (606)
|
Full Article (HTML) (2488)
|
Figures (1-4) (380)
|
Tables (1-5) (404)
|
Full Article (PDF)-6006K (172)
|
Full Article with Cover (PDF)-16750K (150)
|
Full Article (XML)-200K (93)
|
Audio-376K (3)
|
Peer-Review Report-182K (99)
|
Answering Reviewers-60K (98)
|
Supplementary Material-355K (99)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8816)
|
Similar Articles (1871)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis

World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (541)
|
Core Tip (603)
|
Article Highlights (605)
|
Full Article (HTML) (1696)
|
Figures (1-4) (391)
|
Tables (1-4) (399)
|
Full Article (PDF)-5941K (140)
|
Full Article with Cover (PDF)-16687K (124)
|
Full Article (XML)-115K (93)
|
Audio-187K (10)
|
Peer-Review Report-215K (89)
|
Answering Reviewers-37K (102)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7104)
|
Similar Articles (2487)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (571)
|
Core Tip (569)
|
Full Article (HTML) (1365)
|
Figures (1-1) (467)
|
Full Article (PDF)-5068K (150)
|
Full Article with Cover (PDF)-15813K (121)
|
Full Article (XML)-63K (82)
|
Audio-811K (4)
|
Peer-Review Report-266K (97)
|
Answering Reviewers-225K (97)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5749)
|
Similar Articles (4276)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (569)
|
Core Tip (573)
|
Full Article (HTML) (1401)
|
Full Article (PDF)-325K (117)
|
Full Article with Cover (PDF)-11079K (117)
|
Full Article (XML)-24K (94)
|
Audio-243K (2)
|
Peer-Review Report-215K (71)
|
Answering Reviewers-19K (73)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4165)
|
Similar Articles (394)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open